Cancer Vaccines Market Report by Type, (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-cell Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer, and Others), End User (Pediatrics, Adults), and Region 2025-2033
The global cancer vaccines market size reached USD 7.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 19.1 Billion by 2033, exhibiting a growth rate (CAGR) of 9.73% during 2025-2033. The increasing cancer incidence, advancements in immunotherapy, government initiatives ...